We are live on
!
Find out more
IFM
ION Fund Management Portfolio holdings
AUM
$1.58B
This Fund
S&P 500
This Quarter
Est. Return
+11.69%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$857M
AUM Growth
–
Cap. Flow
+$841M
Cap. Flow
% of AUM
98.04%
Top 10 Holdings %
Top 10 Hldgs %
56.09%
Holding
62
New
62
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$99.8M |
| 2 |
Delek US
DK
|
+$63.1M |
| 3 |
Check Point Software Technologies
CHKP
|
+$49.1M |
| 4 |
Illumina
ILMN
|
+$39M |
| 5 |
Danaos Corp
DAC
|
+$38.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 22.7% |
| 3 | Industrials | 12.53% |
| 4 | Energy | 11.11% |
| 5 | Consumer Discretionary | 4.76% |
Similar funds
PCM
KI
RIM
ACM
RWM
BFA
BCP
LLL
ION Fund Management's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for ION Fund Management, which disclosed 62 positions worth $857M. Its ten largest holdings account for 56% of the portfolio.
Its largest position is Teva Pharmaceuticals: 4,050,000 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, followed by Healthcare and Industrials.
- ION Fund Management's largest Q4 2025 buy was Teva Pharmaceuticals: 4,050,000 shares worth $126M.
- ION Fund Management's ten largest holdings make up 56% of its $857M portfolio in Q4 2025.
- ION Fund Management disclosed 62 positions in Q4 2025, its first 13F filing on record.
Based on ION Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.